TL;DR: Promakhos Therapeutics is a Y Combinator Summer 2021 startup A therapeutics platform for curing inflammatory disorders, currently active with a team of 2.
A therapeutics platform for curing inflammatory disorders
Last verified:
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Built by LemStudio
Yes. Promakhos Therapeutics was funded by Y Combinator in the Summer 2021 batch. A therapeutics platform for curing inflammatory disorders
We are building a platform of bacterial molecules to awaken our body’s innate ability to control inflammation and heal. Our first indication is Crohn’s Disease, which affects over 500,000 Americans at an annual cost of $10B. After Crohn's disease, we are going for type 1 Diabetes and Multiple Sclerosis.
Promakhos Therapeutics was part of Y Combinator's Summer 2021 batch.
Promakhos Therapeutics has a team of 2 people according to Y Combinator's directory.
Promakhos Therapeutics is currently listed as Active with a team of 2 in Y Combinator's directory.
Loading interactive view…